T. Rowe Price Exchange-Traded Funds, Inc. (TMED)
管理公司 · XNAS · 系列 S000092023 · 在 SEC EDGAR 上查看 ↗
$36.31
截至 2026年8月21日
▲ +0.41 (+1.13%)
1日变动
$24.99 – $36.72
52周范围
该基金的持仓数据尚未提供。
本页内容
TMED 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
业绩 截至 2026年8月20日
| 期间 | 价格回报 | 总回报 |
|---|---|---|
| 1M | ▲ +20.90% | — |
| 3M | ▲ +20.90% | — |
| 6M | ▲ +21.09% | — |
| 年初至今 | ▲ +20.79% | — |
| 1Y | ▲ +42.73% | — |
| 3Y | — | — |
| 5Y | — | — |
| 最大 自 2025年6月12日 起 | ▲ +42.87% | — |
- 1年波动率
- 28.37%
- 3年波动率
- —
- 3年最大回撤
- —
- 3年Beta值
- —
- 1年夏普比率*
- 2.24
在收集完该基金的股息历史后，将显示总回报率——仅显示价格回报率会产生误导性的重复。回报率未与指数进行基准比较。 * 夏普比率按0%无风险利率计算。
基金流向（SEC报告）
- 上个月（三月 2026）
- +$1.4M
- 截至三月 2026的季度
- +$4.4M
- 过去12个月
- +$18.2M
四月 2025 – 三月 2026
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
完整构成 109 持仓
| 名称 | CUSIP | 价值 | % | 余额 | 类别 | 国家 |
|---|---|---|---|---|---|---|
| ELI LILLY & CO | 532457108 | $2.9M | 14.48 | 3189 | EC | US |
| UNITEDHEALTH GROUP INC | 91324P102 | $1.3M | 6.54 | 4898 | EC | US |
| THERMO FISHER SCIENTIFIC INC | 883556102 | $930K | 4.59 | 1893 | EC | US |
| GILEAD SCIENCES INC | 375558103 | $839K | 4.14 | 6020 | EC | US |
| ABBOTT LABORATORIES | 002824100 | $793K | 3.91 | 7720 | EC | US |
| DANAHER CORP | 235851102 | $553K | 2.73 | 2918 | EC | US |
| MEDTRONIC PLC | G5960L103 | $454K | 2.24 | 5245 | EC | IE |
| ALNYLAM PHARMACEUTICALS INC | 02043Q107 | $418K | 2.06 | 1262 | EC | US |
| STRYKER CORP | 863667101 | $406K | 2.00 | 1235 | EC | US |
| DYNE THERAPEUTICS INC | 26818M108 | $380K | 1.88 | 20969 | EC | US |
| WATERS CORP | 941848103 | $355K | 1.75 | 1192 | EC | US |
| BECTON DICKINSON AND CO | 075887109 | $346K | 1.71 | 2202 | EC | US |
| AGILENT TECHNOLOGIES INC | 00846U101 | $341K | 1.69 | 2996 | EC | US |
| ELANCO ANIMAL HEALTH INC | 28414H103 | $321K | 1.59 | 13428 | EC | US |
| HUMANA INC | 444859102 | $318K | 1.57 | 1835 | EC | US |
| CYTOKINETICS INC | 23282W605 | $311K | 1.54 | 4722 | EC | US |
| WEST PHARMACEUTICAL SERVICES | 955306105 | $300K | 1.48 | 1198 | EC | US |
| BOSTON SCIENTIFIC CORP | 101137107 | $298K | 1.47 | 4745 | EC | US |
| ASCENDIS PHARMA A/S - ADR | 04351P101 | $282K | 1.39 | 1235 | EC | DK |
| BIOGEN INC | 09062X103 | $255K | 1.26 | 1390 | EC | US |
| VAXCYTE INC | 92243G108 | $240K | 1.19 | 4136 | EC | US |
| IMMUNOME INC | 45257U108 | $233K | 1.15 | 10669 | EC | US |
| METTLER-TOLEDO INTERNATIONAL | 592688105 | $224K | 1.11 | 178 | EC | US |
| CENCORA INC | 03073E105 | $215K | 1.06 | 685 | EC | US |
| APELLIS PHARMACEUTICALS INC | 03753U106 | $208K | 1.03 | 5162 | EC | US |
| REGENERON PHARMACEUTICALS | 75886F107 | $206K | 1.02 | 267 | EC | US |
| DEXCOM INC | 252131107 | $204K | 1.01 | 3251 | EC | US |
| CVS HEALTH CORP | 126650100 | $194K | 0.96 | 2698 | EC | US |
| MOONLAKE IMMUNOTHERAPEUTICS | 61559X104 | $181K | 0.89 | 9719 | EC | KY |
| INSULET CORP | 45784P101 | $169K | 0.83 | 803 | EC | US |
| ADAPTIVE BIOTECHNOLOGIES | 00650F109 | $168K | 0.83 | 12084 | EC | US |
| BICARA THERAPEUTICS INC | 055477103 | $165K | 0.82 | 8310 | EC | US |
| BIONTECH SE-ADR | 09075V102 | $163K | 0.80 | 1829 | EC | DE |
| IMMATICS NV | N44445109 | $161K | 0.79 | 16368 | EC | NL |
| REPLIGEN CORP | 759916109 | $160K | 0.79 | 1359 | EC | US |
| COOPER COS INC/THE | 216648501 | $157K | 0.78 | 2197 | EC | US |
| SHATTUCK LABS INC | 82024L103 | $155K | 0.77 | 24111 | EC | US |
| IDEXX LABORATORIES INC | 45168D104 | $149K | 0.74 | 266 | EC | US |
| XENON PHARMACEUTICALS INC | 98420N105 | $149K | 0.73 | 2558 | EC | CA |
| SAREPTA THERAPEUTICS INC | 803607100 | $148K | 0.73 | 6817 | EC | US |
| BRISTOL-MYERS SQUIBB CO | 110122108 | $148K | 0.73 | 2432 | EC | US |
| MOLINA HEALTHCARE INC | 60855R100 | $144K | 0.71 | 1082 | EC | US |
| APOGEE THERAPEUTICS INC | 03770N101 | $140K | 0.69 | 1658 | EC | US |
| CG ONCOLOGY INC | 156944100 | $137K | 0.68 | 2028 | EC | US |
| AGIOS PHARMACEUTICALS INC | 00847X104 | $132K | 0.65 | 3906 | EC | US |
| INCYTE CORP | 45337C102 | $132K | 0.65 | 1398 | EC | US |
| KYMERA THERAPEUTICS INC | 501575104 | $125K | 0.62 | 1497 | EC | US |
| NOVO-NORDISK A/S-SPONS ADR | 670100205 | $118K | 0.58 | 3200 | EC | DK |
| CABALETTA BIO INC | 12674W109 | $117K | 0.58 | 43630 | EC | US |
| ALIGN TECHNOLOGY INC | 016255101 | $109K | 0.54 | 634 | EC | US |
页 1
/ 3
← 上一页
下一页 →
机构持有人 (13F) 4 家申报者
在其季度SEC表格13F中报告持有该ETF的机构。仅限多头头寸；单个申报者可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
| 机构 | 价值 | % 已追踪的13F | 股份 | 类型 | 截至 |
|---|---|---|---|---|---|
| COMMONWEALTH EQUITY SERVICES, LLC | $329060 | 38.98% | 9635 | 股份 | 2026年6月30日 |
| Essex Financial Services, Inc. | $310790 | 36.82% | 9100 | 股份 | 2026年6月30日 |
| CITADEL ADVISORS LLC | $203482 | 24.11% | 5958 | 股份 | 2026年6月30日 |
| FLOW TRADERS U.S. LLC | $814 | 0.10% | 23827 | 股份 | 2026年6月30日 |
同类基金
来自该发行方的更多信息
| 基金 | 资产管理规模 |
|---|---|
| TAGG T. Rowe Price Exchange-Traded... | $1.9B |
| TOUS T. Rowe Price Exchange-Traded... | $1.4B |
| TBUX T. Rowe Price Exchange-Traded... | $1.1B |
| THYF T. Rowe Price Exchange-Traded... | $815.6M |
| TFLR T. Rowe Price Exchange-Traded... | $613.4M |
| TOTR T. Rowe Price Exchange-Traded... | $561.8M |
| TAXE T. Rowe Price Exchange-Traded... | $156.7M |
| TIER T. Rowe Price Exchange-Traded... | $27.6M |
| THYM T. Rowe Price Exchange-Traded... | $25.3M |
| TMNL T. Rowe Price Exchange-Traded... | $22.6M |
规模相似
| 基金 | 资产管理规模 |
|---|---|
| SCAP Series Portfolios Trust | $20.4M |
| MRCP PGIM Rock ETF Trust | $20.5M |
| WANT Direxion Shares ETF Trust | $20.5M |
| AVGB AMERICAN CENTURY ETF TRUST | $20.5M |
| JHAI Janus Detroit Street Trust | $20.5M |
| JULP PGIM Rock ETF Trust | $20.1M |
| GDOC Goldman Sachs ETF Trust | $20.1M |
| TPLS Thornburg ETF Trust | $20.1M |
| SETH ProShares Trust | $20.1M |
| SEPP PGIM Rock ETF Trust | $20.0M |